Business
Sanara MedTech Inc. Announces the Appointment of Zach Fleming and Shawn Bowman as Co-Chief Operating Officers
FORT WORTH, TX / ACCESSWIRE / January 28, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company") (OTCQB:SMTI),
About this update from Sanara Medtech Inc.
[{"type":"text","content":"FORT WORTH, TX / ACCESSWIRE / January 28, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (\"Sanara\" or the \"Company\") (OTCQB:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that the Board of Directors has approved the appointment of Zach Fleming and Shawn Bowman as Co-Chief Operating Officers of the Company. Mr. Fleming currently serves as the President of the Company's Surgical Division, and Mr. Bowman currently serves as the President of the Company's Wound Care Division. They will retain those positions in addition to the new responsibilities with these appointments.Ron Nixon, Sanara's Executive Chairman stated, \"Zach and Shawn are accomplished executives who have exhibited strong leadership as they have built-out the sales and distribution channels in their respective divisions. Their appointments as Co-COO's are meant to ensure that the Company's operations are fully aligned with the current two divisions as well as with the execution of Sanara's strategic initiatives.\"The appointments are effective immediately.About Sanara MedTech Inc.With a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets and distributes wound and skincare products to physicians, hospitals, clinics, and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech markets and distributes CellerateRX® Surgical Activated Collagen® to the surgical markets as well as the following products to the wound care market: BIAKŌS™ Antimicrobial Skin and Wound Cleanser, HYCOL™ Hydrolyzed Collagen, and PULSAR II™ Advanced Wound Irrigation™ (AWI). In addition, Sanara is actively seeking to expand within its six focus areas of wound and skincare for the acute, post-acute, and surgical markets. The focus areas are debridement, biofilm removal, hydrolyzed collagen, advanced biologics, negative pressure wound therapy adjunct products, and the oxygen delivery system segment of the healthcare industry. For more information, visit SanaraMedTech.com.Information about Forward-Looking State...